| Literature DB >> 26616552 |
Laskarina-Maria Korou1, Konstantia E Tasioudi2, Myrsini Tzani3, Athanasios Konstantinidis4, Aikaterini Plevraki5, Peristera Iliadou2, Petroula Kostoglou3, Dimitrios Kaimaras6, Spyridon Doudounakis3, Olga Mangana-Vougiouka2.
Abstract
Following the late 2012 recurrence of rabies in wild foxes (Vulpes vulpes) in central and north-western Greece, the first oral fox vaccination campaign co-financed by the European Union (EU) and the Greek state budget, was implemented. Initially, it involved 24 regional units of the Greek territory during the period October-December 2013. Vaccine-baits were aerially distributed by fixed-wing aircrafts. Vaccines were scattered along parallel flight paths 500m apart in order to optimize aerial missions and achieve homogeneous distribution. A geographical information system was used to objectively evaluate bait distribution. This system identified areas of inadequate bait density that would require additional flights. A total number of 1,504,821 baits were distributed covering an area of 54,584.29km(2). To assess the effectiveness of oral vaccination campaign a monitoring program was introduced, which entailed examination of serum samples and canine teeth derived from red foxes collected in the field. The laboratory analysis revealed 60% seropositivity and detection of tetracycline biomarker in 70% of the foxes tested.Entities:
Keywords: Antibodies; Foxes; Greece; Oral vaccination; Rabies; Tetracycline
Mesh:
Substances:
Year: 2015 PMID: 26616552 DOI: 10.1016/j.vaccine.2015.11.031
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641